Inventor · disambiguated record
William R. Shanahan
Also filed as: SHANAHAN JR WILLIAM R · SHANAHAN WILLIAM · SHANAHAN WILLIAM R · SHANAHAN WILLIAM R JR
9 granted patents·14 pending applications·203 citations·filing 1998–2025
88Inventor score
Files withARENA PHARM INC11ISIS PHARMACEUTICALS INC5ANDERSON CHRISTEN M2SANCHEZ MATILDE1SHANAHAN JR WILLIAM R1
Top patents by PatentIndex Score
23 records- 0192US6228642B1Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted May 8, 2001·91 cites·14 claims
- 0289US11007175B2Methods of treating conditions related to the S1P1 receptorARENA PHARM INC·Filed 2016·Granted May 18, 2021·10 cites·21 claims
- 0388US6080580AAntisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Jun 27, 2000·86 cites·11 claims
- 0484US12377071B2Methods of treating conditions related to the S1P1 receptorARENA PHARM INC·Filed 2024·Granted Aug 5, 2025·0 cites·18 claims
- 0583US8999970B2Administration of an anti-obesity compound to individuals with renal impairmentANDERSON CHRISTEN M·Filed 2011·Granted Apr 7, 2015·9 cites·28 claims
- 0679US9770455B2Administration of an anti-obesity compound to individuals with renal impairmentARENA PHARM INC·Filed 2017·Granted Sep 26, 2017·2 cites·6 claims
- 0779US9169213B2Method of weight managementARENA PHARM INC·Filed 2014·Granted Oct 27, 2015·5 cites·22 claims
- 0879US2025319062A1Methods of treating conditions related to the s1p1 receptorARENA PHARM INC·Filed 2025·Application pending·0 cites
- 0972US11896578B2Methods of treating conditions related to the S1P1 receptorARENA PHARM INC·Filed 2021·Granted Feb 13, 2024·0 cites·15 claims
- 1072US2024122886A1Methods of treatmentARENA PHARM INC·Filed 2023·Application pending·0 cites
- 1169US2009292009A1Modulation of stat 6 expressionISIS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1260US2004115634A1Modulation of stat 6 expressionISIS PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 1358US2005239124A1Modulation of STAT 6 expressionISIS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1456US8518904B2Modulation of STAT 6 expressionSHANAHAN JR WILLIAM R·Filed 2012·Granted Aug 27, 2013·0 cites·20 claims
- 1553US2004152652A1Antisense Oligonucleotide modulation of tumor necrosis factor-alpha (TNF-alpha) expressionFiled 2003·Application pending·0 cites
- 1650US2004142346A1Antisense oligonucleotide modulation of tumor necrosis factor-alpha (TNF-alpha) expressionFiled 2003·Application pending·0 cites
- 1750US2020368190A1Methods of treatmentARENA PHARM INC·Filed 2018·Application pending·0 cites
- 1848US2015297610A1Method of weight managementSANCHEZ MATILDE·Filed 2012·Application pending·0 cites
- 1948US2003022848A1Antisense oligonucleotide modulation of tumor necrosis factor-alpha (TNF-alpha) expressionFiled 2001·Application pending·0 cites
- 2047US2017239263A1Method of weight managementARENA PHARM INC·Filed 2016·Application pending·0 cites
- 2146US2015196567A1Administration of an anti-obesity compound to individuals with renal impairmentARENA PHARM INC·Filed 2015·Application pending·0 cites
- 2241US2013267500A15-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine levelANDERSON CHRISTEN M·Filed 2011·Application pending·0 cites
- 2339US2019160058A1Methods of treatment with selective cb2 receptor agonistsARENA PHARM INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William R. Shanahan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →